Mycobacterium tuberculosis Complex Including Species, Molecular Method
Tuberculosis caused by Mycobacterium tuberculosis (MTB) has been a challenging infection for many decades. In 2012, the incidence of MTB infection was as high as 8.6 million worldwide, affecting both developing and industrialized nations. MTB is second only to human immunodeficiency virus (HIV) as the most lethal infectious agent, with 1.3 million people dying of tuberculosis in 2012. In the US, the incidence of MTB infection is 3.2 persons/100,000 population, with HIV infection and immunosuppression being important predisposing factors. HIV infection also predisposes to infection by Mycobacterium avium complex (MAC), which is somewhat clinically similar to MTB infection. The true incidence of MAC infection is hard to estimate at least in part due to difficulty in the clinical diagnosis of this infection.
Mycobacterial species are broadly classified into two categories – Mycobacterium tuberculosis complex and nontuberculous mycobacteria (atypical mycobacteria). Mycobacterium tuberculosis complex consists of M. tuberculosis (MTB) and closely related species; the clinically important species includes M. bovis, M. bovis BCG, M. africanum, M. microti and M. pinnipedii. The atypical mycobacteria are subclassified based on their growth characteristics and pigment production (in vitro). MAC is a slow grower and does not produce any pigment while M. kansasii grows slowly and produces yellow pigment on the agar plates upon exposure to light (photochromogen). Laboratory identification of mycobacterial species involves isolation from the clinical specimens (through decontamination and purification), extended incubation to include slow growers, growth and pigmentation on agar plates, bacterial morphology (acid-fast stain/Rhodamine-Auramine stain), biochemical characteristics and molecular typing (nucleic acid hybridization, PCR and sequencing).
Clinical presentation of mycobacteria infections is non-specific and poses a diagnostic challenge to the clinician. The presenting symptoms include chronic non-productive cough, low-grade fever, unexplained weight loss, and failure to thrive (in children). Most mycobacterial infections are acquired through respiratory route and cause chronic lung disease including bronchitis, granulomatous abscess, lung nodules (mimicking malignancy), cavitary lung lesions and mediastinal lymphadenopathy. Differential diagnosis remains broad and requires a high index of clinical suspicion to aid the laboratory diagnosis. Specimen collection includes moderately invasive procedures such as sputum induction, bronchial wash, bronchial lavage, mediastinoscopy, etc., which are expensive, time-consuming and associated with anesthetic and interventional risks.
Due to difficulty in obtaining a clinical specimen, it is important to employ highly efficient laboratory techniques, thereby eliminating the need to repeat sample collection. Since the clinical presentation is non-specific, the clinician may not be suspecting mycobacterial infection at the time of sample collection. Newer laboratory techniques such as PCR are geared to overcome this deficiency by their ability to extract and amplify nucleic acids in archival tissues such as formalin-fixed paraffin embedded (FFPE) blocks for molecular typing and speciation of mycobacteria. In addition, today’s multiplex Real-Time PCR assays can detect and differentiate M. tuberculosis and M. tuberculosis species as well as Mycobacterium avium complex that can help diagnosis of tuberculosis vs atypical pneumonia in immunocompromised patients.
- Diagnosis of tuberculosis caused by M. tuberculosis
- Differential diagnosis of tuberculosis caused by Mycobacterium avium complex
- Detection M. tuberculosis, MAC and M. kansasii in formalin-fixed paraffin embedded tissue
- As an aid in diagnosis of atypical pneumonia caused by non-tuberculosis species (MAC, M. intracellulare)
- As an aid in diagnosis of granuloma in immunocompromised patients
Detection of mycobacterial DNA from FFPE tissue implies infection by mycobacterial infectious agent if the histopathologic pattern of injury is consistent with chronic inflammation.
Detection of mycobacterial DNA other than M. tuberculosis such as MAC, M. intracellulare from FFPE tissue implies infection by a non-M. Tuburculosis mycobacterial infectious agent if the histopathologic pattern of injury is consistent (such as granuloma, atypical pneumonia).
Detection of mycobacterial DNA doesn’t always imply disease since it cannot differentiate between active infection and remnant of DNA from resolution of the infection.
This test should not be used to determine response to therapy or document complete resolution. It is unclear as to how long it takes DNA levels to fall below the levels of detection after complete resolution of the disease.
A negative test (mycobacterial DNA not detected) doesn’t rule out mycobacterial disease. Correlation with clinical findings is essential to consider other atypical mycobacterial infections and to evaluate the need for obtaining additional specimen samples.
Not Detect (Negative)
Formalin-fixed paraffin embedded tissue, bronchial wash, Sputum. Bronchial wash and sputum are spun down on CytoSpin™ and then fixed in tissue blocks.
Ship the FFPE tissue block(s) to the laboratory in a clean bag at ambient conditions.
Three sputum specimens should be collected at 8-24 hour intervals (24 hours when possible) and should include at least one first morning specimen.
Bronchoalveolar lavage (BAL), pleural fluid, sputum. Respiratory specimen processed by NaOH-NALC digestion decontamination procedure. Bronchial wash and sputum must be collected in sterile container and then transfer to laboratory refrigerated. Immediately process specimens by cytospin fixing.
- Nat Rev Immunol. 2012 Jul 13;12(8):581-91. [PMID: 22790178]
- Clin Infect Dis. 2011 Jun;52(11):1350-5. [PMID: 21596676]
- PLoS One. 2011;6(9):e24789. [PMID: 21961045]
- Curr Microbiol. 2012 Nov;65(5):493-9. [PMID: 22797866]
- Arch Pathol Lab Med. 2003 May;127(5):554-60. [PMID: 12708897]
- Center for Disease Control, data and statistics on tuberculosis http://www.cdc.gov/TB/statistics/ accessed 10.31.2013
- World Health Organization, factsheets on tuberculosis http://www.who.int/mediacentre/factsheets/fs104/en/ accessed 10.31.2013